Your browser doesn't support javascript.
loading
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.
Gregg, Justin R; Kim, Jeri; Logothetis, Christopher; Hanash, Sam; Zhang, Xiaotao; Manyam, Ganiraju; Muir, Kenneth; Giles, Graham G; Stanford, Janet L; Berndt, Sonja I; Kogevinas, Manolis; Brenner, Hermann; Eeles, Rosalind A; Wei, Peng; Daniel, Carrie R.
Afiliação
  • Gregg JR; Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jrgregg@mdanderson.org.
  • Kim J; Merck & Co., Kenilworth, NJ, USA.
  • Logothetis C; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hanash S; Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang X; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Manyam G; Department of Biostatistics, Division of Basic Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Muir K; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK; Warwick Medical School, University of Warwick, Coventry, UK.
  • Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash Univer
  • Stanford JL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
  • Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Kogevinas M; ISGlobal, Barcelona, Spain; Hospital del Mar Medical Research Institute, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
  • Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, G
  • Eeles RA; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
  • Wei P; Department of Biostatistics, Division of Basic Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daniel CR; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eur Urol Oncol ; 6(3): 282-288, 2023 Jun.
Article em En | MEDLINE | ID: mdl-35995710
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Cafeína Tipo de estudo: Clinical_trials / Prognostic_studies País/Região como assunto: Oceania Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Cafeína Tipo de estudo: Clinical_trials / Prognostic_studies País/Região como assunto: Oceania Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article